Pricing Log in Create free account

ImageneBio, Inc. (IMA) vs Serina Therapeutics, Inc. (SER)

ImageneBio, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. ImageneBio, Inc. and Serina Therapeutics, Inc. are of similar size ($45.7M and $45.5M). ImageneBio, Inc. grew revenue faster over the last twelve months: −68.0% against −94.2%. Across the 14 metrics below, ImageneBio, Inc. leads on 9 and Serina Therapeutics, Inc. on 5.

Valuation

Metric IMA SER Biotechnology median
P/E n/m n/m 8.50
P/S 10.63 160.23 9.71
P/B 0.46 1.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.52 66.04 9.21
Earnings yield (129.11%) (106.78%) (33.15%)
Free cash flow yield (79.05%) (73.10%) (25.50%)

Profitability

Metric IMA SER Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.34%) (306.22%) (56.36%)
Return on assets (38.34%) (136.00%) (48.04%)
Return on invested capital (622.37%) 0.00% 0.00%

Growth

Metric IMA SER Biotechnology median
Revenue growth (TTM) (67.95%) (94.21%) 6.02%
EPS growth (last fiscal year) 21.27% (26.49%) 30.26%
Revenue growth, 5-year CAGR (38.64%) (18.48%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMA SER Biotechnology median
Debt to equity 0.00 0.16 0.00
Current ratio 21.47 6.65 4.72
Net debt to EBITDA 2.85 0.00 0.96

Dividend

Metric IMA SER Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMA SER Biotechnology median
Market cap 45.74m 45.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack